In this paper we revisit the problem of finding an orthogonal similarity transformation that puts an $n\times n$ matrix $A$ in a block upper-triangular form that reveals its Jordan structure at a particular eigenvalue $\lambda_0$. The obtained form in fact reveals the dimensions of the null spaces of $(A-\lambda_0 I)^i$ at that eigenvalue via the sizes of the leading diagonal blocks, and from this the Jordan structure at $\lambda_0$ is then easily recovered. The method starts from a Hessenberg form that already reveals several properties of the Jordan structure of $A$.

In this paper we consider drug binding in the arterialwall following delivery by a drug-eluting stent. Whilst it is now generally accepted that a non-linear saturable reversible binding model is required to properly describe the binding process, the precise form of the binding model varies between authors. Our particular interest in this manuscript is in assessing to what extent modelling specific and non-specific binding in the arterial wall as separate phases is important.

In this paper, we propose a new mathematical model describing the effect of phosphocitrate (PC) on sodium sulphate crystallization inside bricks. This model describes salt and water transport, and crystal formation in a one dimensional symmetry. This is a preliminary study that takes into account mathematically the effects of inhibitors inside a porous stone. To this aim, we introduce two model parameters: the crystallization rate coefficient, which depends on the nucleation rate, and the specific volume of precipitated salt.

Classical results from spectral theory of stationary linear kinetic equations are applied to efficiently approximate two physically relevant weakly nonlinear kinetic models: a model of chemotaxis involving a biased velocity-redistribution integral term, and a Vlasov-Fokker-Planck (VFP) system. Both are coupled to an attractive elliptic equation producing corresponding mean-field potentials.

Vaccination is the most successful and cost-effective method to prevent infectious diseases. However, many vaccine antigens have poor in vivo immunogenic potential and need adjuvants to enhance immune response. The application of systems biology to immunity and vaccinology has yielded crucial insights about how vaccines and adjuvants work. We have previously characterized two safe and powerful delivery systems derived from non-pathogenic prokaryotic organisms: E2 and fd filamentous bacteriophage systems.